Published in J Bacteriol on August 22, 2008
Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol (2010) 1.30
Secretome of obligate intracellular Rickettsia. FEMS Microbiol Rev (2014) 0.89
Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussis. PLoS One (2012) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol (1999) 33.07
NPS@: network protein sequence analysis. Trends Biochem Sci (2000) 9.68
Protein structure prediction servers at University College London. Nucleic Acids Res (2005) 6.70
Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol (2005) 6.16
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol (1996) 5.50
Genetic analysis of phase change in Bordetella pertussis. Infect Immun (1984) 5.03
Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci U S A (1993) 4.12
Characterization of the virB operon from an Agrobacterium tumefaciens Ti plasmid. J Biol Chem (1988) 3.40
Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J Bacteriol (1991) 3.12
Adaptation of a conjugal transfer system for the export of pathogenic macromolecules. Trends Microbiol (1996) 2.74
Use of conditionally counterselectable suicide vectors for allelic exchange. Methods Enzymol (1994) 2.18
Gene-for-genes interactions between cotton R genes and Xanthomonas campestris pv. malvacearum avr genes. Mol Plant Microbe Interact (1993) 2.10
Agrobacterium tumefaciens VirB6 protein participates in formation of VirB7 and VirB9 complexes required for type IV secretion. J Bacteriol (2003) 1.58
VirB6 is required for stabilization of VirB5 and VirB3 and formation of VirB7 homodimers in Agrobacterium tumefaciens. J Bacteriol (2000) 1.40
Agrobacterium tumefaciens VirB6 domains direct the ordered export of a DNA substrate through a type IV secretion System. J Mol Biol (2004) 1.39
Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J Bacteriol (1994) 1.28
Evidence for a ninth gene, ptlI, in the locus encoding the pertussis toxin secretion system of Bordetella pertussis and formation of a PtlI-PtlF complex. J Biol Chem (1996) 1.26
The type IV secretion apparatus protein VirB6 of Agrobacterium tumefaciens localizes to a cell pole. Mol Microbiol (2005) 1.16
Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis. Infect Immun (2000) 1.05
Mutants in the ptlA-H genes of Bordetella pertussis are deficient for pertussis toxin secretion. FEMS Microbiol Lett (1999) 0.98
Requirements for assembly of PtlH with the pertussis toxin transporter apparatus of Bordetella pertussis. Infect Immun (2007) 0.87
Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis. Infect Immun (2004) 0.80
Importance of srtA and srtB for growth of Bacillus anthracis in macrophages. Infect Immun (2005) 1.03
Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin Vaccine Immunol (2009) 0.99
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. PLoS One (2013) 0.94
Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clin Vaccine Immunol (2012) 0.92
Comparison of three anthrax toxin neutralization assays. Clin Vaccine Immunol (2010) 0.92
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen. Infect Immun (2012) 0.89
Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action. Clin Vaccine Immunol (2012) 0.89
Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections. Clin Vaccine Immunol (2014) 0.87
Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion. Infect Immun (2002) 0.87
Requirements for assembly of PtlH with the pertussis toxin transporter apparatus of Bordetella pertussis. Infect Immun (2007) 0.87
Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay. Clin Vaccine Immunol (2008) 0.85
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays. Clin Vaccine Immunol (2010) 0.80
Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis. Infect Immun (2004) 0.80
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations. J Infect Dis (2014) 0.78
The case for developing consensus standards for research in microbial pathogenesis: Bacillus anthracis toxins as an example. Infect Immun (2009) 0.77
Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus. Infect Immun (2004) 0.77
Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants. Clin Vaccine Immunol (2013) 0.77